Panacea Life Sciences Holdings, Inc. PLSH
We take great care to ensure that the data presented and summarized in this overview for PANACEA LIFE SCIENCES HOLDINGS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in PLSH
Top Purchases
Top Sells
About PLSH
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals. It is also involved in the personal protection equipment (PPE) business, including importing and selling PPE hand sanitizers and masks, as well as white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
Insider Transactions at PLSH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+1.29%
|
$0
$0.24 P/Share
|
|
Jun 09
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.2%
|
$0
$0.43 P/Share
|
|
Jun 02
2023
|
Leslie Buttorff CEO |
BUY
Grant, award, or other acquisition
|
Direct |
760,000
+33.47%
|
$0
$0.5 P/Share
|
|
May 23
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.07%
|
$0
$0.5 P/Share
|
|
May 19
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
6,000
+0.4%
|
$0
$0.52 P/Share
|
|
May 09
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
2,300
+0.31%
|
$0
$0.38 P/Share
|
|
May 08
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
1,500
+0.2%
|
$0
$0.43 P/Share
|
|
May 05
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
11,500
+1.53%
|
$0
$0.49 P/Share
|
|
Apr 26
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
5,500
+0.75%
|
$0
$0.4 P/Share
|
|
Apr 25
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
4,500
+0.31%
|
$0
$0.35 P/Share
|
|
Apr 05
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.35%
|
$0
$0.33 P/Share
|
|
Apr 04
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
3,200
+0.45%
|
$0
$0.35 P/Share
|
|
Apr 03
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.14%
|
$0
$0.36 P/Share
|
|
Feb 27
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+0.21%
|
$0
$0.18 P/Share
|
|
Feb 26
2023
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.14%
|
$0
$0.19 P/Share
|
|
Aug 26
2022
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
15,000
+0.75%
|
$0
$0.14 P/Share
|
|
Aug 11
2022
|
Lawrence Wert Director |
BUY
Open market or private purchase
|
Direct |
15,000
+0.38%
|
$0
$0.13 P/Share
|
|
Aug 04
2022
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
17,800
+0.35%
|
$0
$0.1 P/Share
|
|
Aug 03
2022
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.16%
|
$0
$0.1 P/Share
|
|
Jul 11
2022
|
Leslie Buttorff CEO |
BUY
Open market or private purchase
|
Direct |
3,600
+0.19%
|
$0
$0.43 P/Share
|